260 related articles for article (PubMed ID: 14604889)
21. c-Myc-regulated microRNAs modulate E2F1 expression.
O'Donnell KA; Wentzel EA; Zeller KI; Dang CV; Mendell JT
Nature; 2005 Jun; 435(7043):839-43. PubMed ID: 15944709
[TBL] [Abstract][Full Text] [Related]
22. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
Yasui M; Yamamoto H; Ngan CY; Damdinsuren B; Sugita Y; Fukunaga H; Gu J; Maeda M; Takemasa I; Ikeda M; Fujio Y; Sekimoto M; Matsuura N; Weinstein IB; Monden M
Clin Cancer Res; 2006 Aug; 12(15):4720-9. PubMed ID: 16899623
[TBL] [Abstract][Full Text] [Related]
23. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells.
Uto H; Ido A; Moriuchi A; Onaga Y; Nagata K; Onaga M; Tahara Y; Hori T; Hirono S; Hayashi K; Tsubouchi H
Cancer Res; 2001 Jun; 61(12):4779-83. PubMed ID: 11406552
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells.
Matteucci E; Castoldi R; Desiderio MA
J Cell Physiol; 2001 Mar; 186(3):387-96. PubMed ID: 11169978
[TBL] [Abstract][Full Text] [Related]
25. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
[TBL] [Abstract][Full Text] [Related]
26. Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines.
Cagnoli M; Barbieri F; Bruzzo C; Alama A
Gynecol Oncol; 1998 Sep; 70(3):372-7. PubMed ID: 9790790
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
29. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 overexpression induces epidermal growth factor-independent resistance to apoptosis linked to BCL-2 in human A431 carcinoma.
Rieber M; Rieber MS
Apoptosis; 2006 Jan; 11(1):121-9. PubMed ID: 16374552
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
32. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death.
Meyer K; Basu A; Saito K; Ray RB; Ray R
Virology; 2005 Jun; 336(2):198-207. PubMed ID: 15892961
[TBL] [Abstract][Full Text] [Related]
34. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
Galanti G; Fisher T; Kventsel I; Shoham J; Gallily R; Mechoulam R; Lavie G; Amariglio N; Rechavi G; Toren A
Acta Oncol; 2008; 47(6):1062-70. PubMed ID: 17934890
[TBL] [Abstract][Full Text] [Related]
35. Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway.
Farhana L; Dawson M; Rishi AK; Zhang Y; Van Buren E; Trivedi C; Reichert U; Fang G; Kirschner MW; Fontana JA
Cancer Res; 2002 Jul; 62(13):3842-9. PubMed ID: 12097298
[TBL] [Abstract][Full Text] [Related]
36. E2F1 messenger RNA is destabilized in response to a growth inhibitor in normal human keratinocytes but not in a squamous carcinoma cell line.
Saunders NA; Dicker AJ; Jones SJ; Dahler AL
Cancer Res; 1998 Apr; 58(8):1646-9. PubMed ID: 9563476
[TBL] [Abstract][Full Text] [Related]
37. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
Lindström MS; Wiman KG
Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
[TBL] [Abstract][Full Text] [Related]
38. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
39. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
Garneau H; Paquin MC; Carrier JC; Rivard N
J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
[TBL] [Abstract][Full Text] [Related]
40. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma.
Eymin B; Gazzeri S; Brambilla C; Brambilla E
Oncogene; 2001 Mar; 20(14):1678-87. PubMed ID: 11313916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
